Abstract
Liver metastases that can no longer be identified on radiographic images after chemotherapy are termed disappearing metastases. This most commonly occurs in patients with multifocal bilobar metastases of differing size who are extensively treated with chemotherapy. The most effective treatment for disappearing liver metastases is prevention, through the use of high-quality pretreatment imaging, early involvement of a liver surgeon, and limitation of neoadjuvant chemotherapy to as few cycles as are needed for the metastases to become resectable. If a treated metastasis cannot be identified on CT, then MRI should be used to confirm a true disappearance. As the disappearance of a metastasis does not necessarily signify a pathologic complete response at that site, when possible, resection of liver metastases should include all sites that initially contained disease. If this is not possible, then these patients can be considered for other local therapies and should be followed closely for disease recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Buyse M, Thirion P, Carlson RW, et al. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet. 2000;356:373–8.
Dy GK, Krook JE, Green EM, et al. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741. J Clin Oncol. 2007;25:3469–74.
Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644–57. discussion 657-8.
Elias D, Youssef O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol. 2004;86:4–9. This is an important manuscipt in the field as it formally defined the terms disappearing liver metastasis and missing liver metastases.
Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24:3939–45.
Elias D, Goere D, Boige V, et al. Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol. 2007;14:3188–94. This important paper explains the role of adjuvant HAI chemotherapy in the treatment of patients with missing metastases.
Fiorentini G, Del Conte A, De Simone M, et al. Complete response of colorectal liver metastases after intra-arterial chemotherapy. Tumori. 2008;94:489–92.
Tanaka K, Takakura H, Takeda K, et al. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg. 2009;250:935–42. This is another recent paper that contributes to our understanding of the issues related to disappeared lesions after systemic therapy.
Auer RC, White RR, Kemeny NE, et al. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer. 2010;116:1502–9. This is an important recent study that specifically sought to identify risk factors for pathologic response in disappeared metastases.
van Vledder MG, de Jong MC, Pawlik TM, et al. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg. 2010;14:1691–700. This recent publication nicely outlines the scope of the issues regarding disappearing liver metastases.
Adam R, Wicherts DA, de Haas RJ, et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol. 2008;26:1635–41.
Goèré D, Gaujoux S, Deschamp F, et al. Patients operated on for initially unresectable colorectal liver metastases with missing metastases experience a favorable long-term outcome. Ann Surg. 2011;254:114–8. This important recent publication documents a favorable long-term outcome in patients with missing metastases.
Gaujoux S, Goere D, Dumont F, et al. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg. 2011;28:114–20.
Blazer 3rd DG, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26:5344–51. This manuscript clearly demonstrated the positive relationship between response to systemic chemotherapy and long-term survivals.
Adams RB, Aloia TA, Loyer E, et al. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91–103.
Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.
Pawlik TM, Olino K, Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007;11:860–8.
Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer. 1998;77:2008–11.
Zalinski S, Abdalla EK, Mahvash A, Vauthey JN. A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy. Ann Surg Oncol. 2009;16:1208–11.
Motosugi U, Ichikawa T, Nakajima H, et al. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age? J Comput Assist Mogr. 2009;33:266–72.
Onishi H, Murakami T, Kim T, et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology. 2006;239:131–8.
van Kessel CS, Buckens CF, van den Bosch MA, et al. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19:2805–13.
van Kessel CS, van Leeuwen MS, van den Bosch MA, et al. Accuracy of multislice liver CT and MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy. Dig Surg. 2011;28:36–43.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Amanda Cooper and Thomas A. Aloia declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cooper, A., Aloia, T.A. Managing Disappearing Liver Metastases Following Chemotherapy. Curr Colorectal Cancer Rep 10, 204–210 (2014). https://doi.org/10.1007/s11888-014-0215-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11888-014-0215-8